Genomic susceptibility in practice: The regulatory trajectory of non-rare thrombophilia (NRT) genetic tests in the clinical management of venous thrombo-embolism (VTE)

Mauro Turrini; Catherine Bourgain

doi:10.1016/j.socscimed.2020.112903

Journal articles

Genomic susceptibility in practice: The regulatory trajectory of non-rare thrombophilia (NRT) genetic tests in the clinical management of venous thrombo-embolism (VTE)

Mauro Turrini ^{1, 2, 3} Catherine Bourgain ³

1 IPP - Institute of Public Goods and Policies

2 CSIC - Spanish National Research Council [Madrid]

3 CERMES3 - UMR 8211 / U988 / UM 7 - CERMES3 - Centre de recherche Médecine, sciences, santé, santé mentale, société

Document type :

Journal articles

Domain :

Humanities and Social Sciences

Complete list of metadata

https://hal-cnrs.archives-ouvertes.fr/hal-03480147
Contributor : Colette ORANGE Connect in order to contact the contributor
Submitted on : Tuesday, December 14, 2021 - 3:18:03 PM
Last modification on : Thursday, April 7, 2022 - 1:58:21 PM

Genomic susceptibility in practice: The regulatory trajectory of non-rare thrombophilia (NRT) genetic tests in the clinical management of venous thrombo-embolism (VTE)

Identifiers

Collections

Citation

Export

Metrics

13

Genomic susceptibility in practice: The regulatory trajectory of non-rare thrombophilia (NRT) genetic tests in the clinical management of venous thrombo-embolism (VTE)

Identifiers

Collections

Citation

Export

Share

Metrics

13